Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Targeted Medical Pharma launches new division to manufacture and distribution dietary supplements

Targeted Medical Pharma, Inc., a biotechnology company that develops and distributes prescription medical foods to physicians and pharmacies, today announced the launch of a new division that will specialize in the manufacturing and distribution of a proprietary line of dietary supplements.

30 Aug 2013

UT finds way to blend passion for chemistry with ideals of environmental sustainability

A University of Texas at Arlington junior who found a way to blend a passion for chemistry with ideals of environmental sustainability is getting help from the U.S. Environmental Protection Agency to further his education and his research.

29 Aug 2013

Future of biomedical innovation depends on new trend for all players to work together for common goal

It's a long, expensive, risky road to turn a scientific breakthrough into a treatment that can help patients. Fewer organizations are trying to tackle the challenges alone, says a new paper from MIT researchers published August 28 in the journal Science Translational Medicine.

29 Aug 2013

Researchers develop ddPCR technology to quantify rejection biomarker in organ transplant injury

A recently reported blood test for the early detection of organ transplant injury could enable more timely therapeutic intervention in transplant patients and thus help to avoid longer term damage. As described by scientists at the University Medical Center G-ttingen and Chronix Biomedical, a molecular diagnostics company, the new method uses Bio-Rad Laboratories' Droplet Digital PCR (ddPCR-) technology to overcome the obstacles of earlier tests, which were both time-consuming and costly.

28 Aug 2013

Fluoride added to water supplies reduces tooth decay in children

Fluoride is a naturally occurring mineral in water and many foods. In addition, fluoride is intentionally added to the public water supplies, because it has been demonstrated that communities with fluoride added to their water supplies have significantly reduced incidence of tooth decay in children.

28 Aug 2013

2ml deep well plate launched by Porvair Sciences

Porvair Sciences has developed the first 96-well round deep well plate that genuinely delivers 2.00 ml liquid capacity / well in an automation compatible SLAS / ANSI footprint. The revolutionary "common wall" design provides a full 2ml round well, round bottom well within a 45mm height limit, thus ensuring full compatibility with most plate handling equipment.

From Porvair Sciences Limited 27 Aug 2013

Sangamo BioSciences signs definitive agreement to buy Ceregene

Sangamo BioSciences, Inc. announced that it signed a definitive agreement to acquire Ceregene, Inc., a privately held biotechnology company focused on developing adeno-associated virus gene therapies.

26 Aug 2013

TRS receives FDA approval for Cranial Bone Void Filler product

Tissue Regeneration Systems, Inc. today announced that it has received 510K approval from the U.S. Food and Drug Administration for its Cranial Bone Void Filler product, indicated for use in the repair of neurosurgical burr holes.

26 Aug 2013

FDA grants marketing approval for VALCHLOR gel for treatment of early stage CTCL

Ceptaris Therapeutics, Inc., a privately held, specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration has granted marketing approval for the orphan drug VALCHLOR (mechlorethamine) gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy.

26 Aug 2013

Adimab Scores Two Deals And Some Milestone Payments

...

22 Aug 2013

Novartis starts shipment of 2013-2014 seasonal influenza vaccines to US customers

Novartis announced today that it has begun shipment of its seasonal influenza vaccines to customers in the US market for the 2013-2014 season. Novartis plans to ship a minimum of 30 million doses of its influenza vaccines to the US market, including Fluvirin (Influenza Virus Vaccine), approved for use in people 4 years of age and older, and Flucelvax (Influenza Virus Vaccine), approved for use in adults 18 years of age and older.

22 Aug 2013

Children with high BPA levels have higher odds of obesity and abnormal waist circumference

Children who have higher levels of Bisphenol A (BPA), a chemical previously used in many products for kids, like baby bottle and plastic toys, had a higher odds of obesity and adverse levels of body fat, according to a new study from University of Michigan researchers.

20 Aug 2013

Tel-Aviv Stock Exchange approves new listing of OPKO's common stock

OPKO Health, Inc. (NYSE: OPK), a multi-national biopharmaceutical and diagnostics company, today announced that the Tel-Aviv Stock Exchange ("TASE") has approved the new listing of OPKO's common stock on the TASE beginning on August 21, 2013, under the ticker symbol OPK. OPKO's common stock will thereafter be listed on both the NYSE in the United States and the TASE in Israel.

19 Aug 2013

Second GSK intramuscular quadrivalent influenza vaccine approved by the FDA

GlaxoSmithKline plc [LSE/NYSE: GSK] announced that the U.S. Food and Drug Administration (FDA) has approved FLULAVAL® QUADRIVALENT (Influenza Virus Vaccine) for the active immunization of persons three years of age and older to help prevent disease caused by seasonal influenza (flu) virus subtypes A and B contained in the vaccine.

19 Aug 2013

Arrays of nanoscale sensors detect flaws in drugs and help improve production

MIT chemical engineers have discovered that arrays of billions of nanoscale sensors have unique properties that could help pharmaceutical companies produce drugs - especially those based on antibodies - more safely and efficiently.

17 Aug 2013

Harvard University receives grant to use organs-on-chips device to test human response to radiation

A team at the Wyss Institute for Biologically Inspired Engineering at Harvard University has received a $5.6 million grant award from the United States Food and Drug Administration (FDA) to use its Organs-on-Chips technology for a novel application of keen interest to national security and health officials: to test human physiological responses to radiation, and to evaluate drugs designed to counter those effects.

13 Aug 2013

Eisai's investigational compound receives orphan drug designation for cutaneous t-cell lymphoma

Eisai Inc. announced today that the U.S. Food and Drug Administration has granted orphan drug designation to its investigational compound (E7777) for cutaneous t-cell lymphoma. E7777 is designed to have an improved purity profile and manufacturing process.

9 Aug 2013

Investigational malaria vaccine offers protection against malaria infection in healthy adults

An investigational malaria vaccine has been found to be safe, to generate an immune system response, and to offer protection against malaria infection in healthy adults, according to the results of an early-stage clinical trial published Aug. 8 in the journal Science.

9 Aug 2013

Molex signs definitive agreements to acquire FCT Electronics Group

Molex Incorporated, a global electronics components company, announced today it has signed definitive agreements to acquire FCT Electronics Group, based in Munich, Germany. FCT Electronics Group specializes in designing and manufacturing custom mixed-layout connectors and cable assemblies.

7 Aug 2013

First Edition: August 5, 2013

Kaiser Health News staff writer Jordan Rau reports: "Medicare will levy $227 million in fines against hospitals in every state but one for the second round of the government's campaign to reduce the number of patients readmitted within a month, according to federal records released Friday" (Rau, 8/2).

5 Aug 2013

Manufacturing News and Research

Further Reading

Targeted Medical Pharma launches new division to manufacture and distribution dietary supplements

UT finds way to blend passion for chemistry with ideals of environmental sustainability

Future of biomedical innovation depends on new trend for all players to work together for common goal

Researchers develop ddPCR technology to quantify rejection biomarker in organ transplant injury

Fluoride added to water supplies reduces tooth decay in children

2ml deep well plate launched by Porvair Sciences

Sangamo BioSciences signs definitive agreement to buy Ceregene

TRS receives FDA approval for Cranial Bone Void Filler product

FDA grants marketing approval for VALCHLOR gel for treatment of early stage CTCL

Adimab Scores Two Deals And Some Milestone Payments

Novartis starts shipment of 2013-2014 seasonal influenza vaccines to US customers

Children with high BPA levels have higher odds of obesity and abnormal waist circumference

Tel-Aviv Stock Exchange approves new listing of OPKO's common stock

Second GSK intramuscular quadrivalent influenza vaccine approved by the FDA

Arrays of nanoscale sensors detect flaws in drugs and help improve production

Harvard University receives grant to use organs-on-chips device to test human response to radiation

Eisai's investigational compound receives orphan drug designation for cutaneous t-cell lymphoma

Investigational malaria vaccine offers protection against malaria infection in healthy adults

Molex signs definitive agreements to acquire FCT Electronics Group

First Edition: August 5, 2013

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest Life Science News